Transcription regulation by mutant p53
- 2 April 2007
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 26 (15) , 2202-2211
- https://doi.org/10.1038/sj.onc.1210294
Abstract
In addition to the loss of wild-type p53 activity, a high percentage of tumor cells accumulate mutant p53 protein isoforms. Whereas the hallmark of the wild-type p53 is its tumor suppressor activities, tumor-associated mutant p53 proteins acquire novel functions enabling them to promote a large spectrum of cancer phenotypes. During the last years, it became clear that tumor-associated mutant p53 proteins are not only distinct from the wild-type p53, but they also represent a heterogeneous population of proteins with a variety of structure–function features. One of the major mechanisms underlying mutant p53 gain of function is the ability to regulate gene expression. Although a large number of specific target genes were identified, the molecular basis for this regulation is not fully elucidated. This review describes the present knowledge about the transcriptional activities of mutant p53 and the mechanisms that might underlie its target gene specificity.Keywords
This publication has 88 references indexed in Scilit:
- Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13-Acetate–Induced Death by Attenuating Activating Transcription Factor 3 InductionCancer Research, 2006
- Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulationCancer Cell, 2006
- Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expressionOncogene, 2005
- Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutantsOncogene, 2002
- Rescuing the function of mutant p53Nature Reviews Cancer, 2001
- Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNABiochemical and Biophysical Research Communications, 2000
- Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapyOncogene, 1999
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.Proceedings of the National Academy of Sciences, 1979